Stephen Chang

1.2k total citations
23 papers, 761 citations indexed

About

Stephen Chang is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Stephen Chang has authored 23 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Pathology and Forensic Medicine and 5 papers in Hematology. Recurrent topics in Stephen Chang's work include Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Stephen Chang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Stephen Chang collaborates with scholars based in United States, France and Italy. Stephen Chang's co-authors include Danelle F. James, Lori Styles, Indu Lal, Aaron C. Logan, Edmund K. Waller, Corey Cutler, Mukta Arora, David B. Miklos, Samantha Jaglowski and Madan Jagasia and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Stephen Chang

23 papers receiving 745 citations

Peers

Stephen Chang

GENET

HEMAT

PFM

IMMUN

F. Matzkies Germany

Silvia Costantini Italy

Naomi B. Klarenbeek Netherlands

Hossein Sadrzadeh United States

Jarosław Piszcz Poland

Sunao Maki Japan

Ziad Salem Lebanon

Roberta Camilla Italy

Jingwen Wang China

L. Engstedt Sweden

F. Matzkies Germany

Stephen Chang

232 ×0.7

GENET

263 ×0.8

HEMAT

158 ×0.7

PFM

184 ×0.9

IMMUN

67 ×0.7

Citations per year, relative to Stephen Chang Stephen Chang (= 1×) peers F. Matzkies

Countries citing papers authored by Stephen Chang

Since Specialization

Citations

This map shows the geographic impact of Stephen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Chang more than expected).

Fields of papers citing papers by Stephen Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Chang. The network helps show where Stephen Chang may publish in the future.

Co-authorship network of co-authors of Stephen Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Chang. A scholar is included among the top collaborators of Stephen Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Chang. Stephen Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chow, Pierce K. H., Stephen Chang, Peng Soon Koh, et al.. (2025). Asia–Pacific modified Delphi consensus conference on large hepatocellular carcinoma. HPB. 27(11). 1355–1366. 1 indexed citations

Waller, Edmund K., David B. Miklos, Corey Cutler, et al.. (2019). Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study. Biology of Blood and Marrow Transplantation. 25(10). 2002–2007. 66 indexed citations

O’Brien, Susan, John C. Byrd, Peter Hillmen, et al.. (2019). Outcomes with ibrutinib by line of therapy and post‐ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis. American Journal of Hematology. 94(5). 554–562. 22 indexed citations

O’Brien, Susan, Peter Hillmen, Steven Coutré, et al.. (2018). Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 18(10). 648–657.e15. 63 indexed citations

Miklos, David B., Corey Cutler, Mukta Arora, et al.. (2017). Ibrutinib for chronic graft-versus-host disease after failure of prior therapy. Blood. 130(21). 2243–2250. 312 indexed citations

O’Brien, Susan, John C. Byrd, Peter Hillmen, et al.. (2016). Outcomes with ibrutinib by line of therapy in patients with CLL: Analyses from phase III data.. Journal of Clinical Oncology. 34(15_suppl). 7520–7520. 13 indexed citations

Montillo, Marco, Susan O’Brien, Alessandra Tedeschi, et al.. (2014). Autoimmune Hemolytic Anemia and Immune Mediated Thrombocytopenia in the Phase III RESONATETM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Including a Case Report. Blood. 124(21). 5654–5654. 11 indexed citations

Hauser, Robert A., et al.. (2012). AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies. Journal of Neural Transmission. 120(2). 299–307. 19 indexed citations

Chang, Stephen, Danos C. Christodoulou, Joshua Gorham, et al.. (2011). IDENTIFYING NOVEL MOLECULAR MECHANISMS IN DILATED CARDIOMYOPATHY: INSIGHTS INTO TREATMENT AND PREVENTION. Journal of the American College of Cardiology. 57(14). E335–E335. 1 indexed citations

10.

Tong, Sandra, Stephen E. Daniels, Peter M. Black, et al.. (2011). Novel p38α Mitogen‐Activated Protein Kinase Inhibitor Shows Analgesic Efficacy in Acute Postsurgical Dental Pain. The Journal of Clinical Pharmacology. 52(5). 717–728. 32 indexed citations

11.

Salvatori, Roberto, Lisa B. Nachtigall, David M. Cook, et al.. (2009). Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly. Pituitary. 13(2). 115–122. 54 indexed citations

12.

Iyer, Shridhar Ganpathi, et al.. (2009). Expanding the Donor Pool for Liver Transplantation in the Setting of an “Opt-out” Scheme – 3 years after New Legislation. Annals of the Academy of Medicine Singapore. 38(4). 315–321. 10 indexed citations

13.

Pickering, Lisa, Karel Cwiertka, Jacek Jassem, et al.. (2006). HematideTM, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), Assessed for Correction of Anemia in Oncology Patients Receiving Chemotherapy.. Blood. 108(11). 1290–1290. 2 indexed citations

14.

Yancy, Clyde W. & Stephen Chang. (2003). Better outcomes in heart failure in African Americans despite negative risk factors; a report from the ADHERE™ database. Journal of Cardiac Failure. 9(5). S82–S82. 2 indexed citations

15.

Fonarow, Gregg C., Clyde W. Yancy, & Stephen Chang. (2003). Variation in heart failure quality of care indicators among U.S. hospitals: analysis of 230 hospitals in the ADHERE registry. Journal of Cardiac Failure. 9(5). S82–S82. 8 indexed citations

16.

Sramek, John J., et al.. (1994). Pilot efficacy trial of abt‐200 in patients with major depressive disorder. 2(6). 315–318. 2 indexed citations

17.

Chang, Stephen, David Ng, Lisa Baird, & Costa Georgopoulos. (1991). Analysis of an Escherichia coli dnaB temperature-sensitive insertion mutation and its cold-sensitive extragenic suppressor. Journal of Biological Chemistry. 266(6). 3654–3660. 17 indexed citations

18.

Hawkinson, R W, et al.. (1989). Performance of a new transdermal nitroglycerin adhesive patch formulation.. PubMed. 11(2). 225–31. 5 indexed citations

19.

McQuinn, Roy L., P J Pentikäinen, Stephen Chang, & Gordon J. Conard. (1988). Pharmacokinetics of flecainide in patients with cirrhosis of the liver. Clinical Pharmacology & Therapeutics. 44(5). 566–572. 24 indexed citations

20.

Chang, Stephen & William J. Kennedy. (1987). Error-free computer solution of certain systems of linear equations. Journal of Computational and Applied Mathematics. 18(3). 279–287. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact